BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31563041)

  • 1. The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities.
    Green AM; Weitzman MD
    DNA Repair (Amst); 2019 Nov; 83():102700. PubMed ID: 31563041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC3A damages the cellular genome during DNA replication.
    Green AM; Landry S; Budagyan K; Avgousti DC; Shalhout S; Bhagwat AS; Weitzman MD
    Cell Cycle; 2016; 15(7):998-1008. PubMed ID: 26918916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases.
    Ng JCF; Quist J; Grigoriadis A; Malim MH; Fraternali F
    Nucleic Acids Res; 2019 Feb; 47(3):1178-1194. PubMed ID: 30624727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC3 proteins and genomic stability: the high cost of a good defense.
    Narvaiza I; Landry S; Weitzman MD
    Cell Cycle; 2012 Jan; 11(1):33-8. PubMed ID: 22157092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle.
    Chiu YL; Greene WC
    J Biol Chem; 2006 Mar; 281(13):8309-12. PubMed ID: 16407183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOBEC3 inhibition of mouse mammary tumor virus infection: the role of cytidine deamination versus inhibition of reverse transcription.
    MacMillan AL; Kohli RM; Ross SR
    J Virol; 2013 May; 87(9):4808-17. PubMed ID: 23449789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.
    Roelofs PA; Martens JWM; Harris RS; Span PN
    Clin Cancer Res; 2023 May; 29(9):1658-1669. PubMed ID: 36478188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential.
    Butler K; Banday AR
    J Hematol Oncol; 2023 Mar; 16(1):31. PubMed ID: 36978147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
    Wang J; Shaban NM; Land AM; Brown WL; Harris RS
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deaminase-Dead Mouse APOBEC3 Is an
    Stavrou S; Zhao W; Blouch K; Ross SR
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer.
    Petljak M; Green AM; Maciejowski J; Weitzman MD
    Nat Genet; 2022 Nov; 54(11):1599-1608. PubMed ID: 36280735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
    Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase.
    Adolph MB; Ara A; Chelico L
    J Mol Biol; 2019 Mar; 431(7):1339-1352. PubMed ID: 30797859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell leukemia virus type I is resistant to the antiviral effects of APOBEC3.
    Ohsugi T; Koito A
    J Virol Methods; 2007 Jan; 139(1):93-6. PubMed ID: 17123636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
    Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination.
    Gillick K; Pollpeter D; Phalora P; Kim EY; Wolinsky SM; Malim MH
    J Virol; 2013 Feb; 87(3):1508-17. PubMed ID: 23152537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cytidine deaminases on innate immune responses against human viral infections.
    Vieira VC; Soares MA
    Biomed Res Int; 2013; 2013():683095. PubMed ID: 23865062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion.
    Nowarski R; Kotler M
    Cancer Res; 2013 Jun; 73(12):3494-8. PubMed ID: 23598277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3.
    Minkah N; Chavez K; Shah P; Maccarthy T; Chen H; Landau N; Krug LT
    Virology; 2014 Apr; 454-455():215-26. PubMed ID: 24725948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains.
    Hakata Y; Landau NR
    J Biol Chem; 2006 Dec; 281(48):36624-31. PubMed ID: 17020885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.